Delivery Order SPE2DB22D3004-SPE2DB24FPC92
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,498.54 firm fixed-price contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product. The award has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The order has a potential value of $1,891.09 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $11,906.52 order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products, with a completion date of January 18, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts from DLA to provide pharmaceuticals, medical supplies, and related...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialty pharmaceutical product, with a potential value of $1,412.60 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, providing a wide range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceuticals, with a potential value of $3,287.76. The delivery order has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, and no set-aside designation was used. This award is associated with a larger,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceuticals. The contract has a potential value of $10,598.71 and a completion date of January 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of a pharmaceutical product - VICTOZA 3-PAK 18 MG/3 ML PEN 3ML. This contract has a potential value of $7,125.13 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not a set-aside contract. The company also holds an indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $8,550.85 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. This order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, is a major...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,128.68 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medication, with a completion date of February 1, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The contract, which has a potential value of $2,838.72, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the sole prime contractor on this award, which is not set aside for any small business or disadvantaged business designations. In...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPC92Delivery Order
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The order has a potential value of $5,483.52 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation, is providing these brand name medications to support military treatment programs and facilities through an indefinite delivery contract (IDC) with DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, is the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceuticals and medical supplies to the Department of Defense. This specific delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 1/29/24 |